Ipragliflozin/ja: Difference between revisions
Ipragliflozin/ja
Created page with "イプラグリフロジン" Tags: Mobile edit Mobile web edit |
Created page with "{{Pathnav|Medication/ja|Diabetes medication/ja|SGLT2 inhibitor/ja|frame=1}} {{Infobox drug | drug_name = | IUPAC_name = (1''S'')-1,5-Anhydro-1-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-<small>D</small>-glucitol <!-- Chemspider ---> | image = Ipragliflozin structure.svg | width = 275 | image2 = Haworth projection of ipragliflozin.svg | width2 = 225 | caption = Haworth projection/ja (bottom)" Tags: Mobile edit Mobile web edit |
||
| Line 1: | Line 1: | ||
<languages /> | <languages /> | ||
{{Pathnav|Medication/ja|Diabetes medication/ja|SGLT2 inhibitor/ja|frame=1}} | |||
{{Pathnav|Medication|Diabetes medication|SGLT2 inhibitor|frame=1 | |||
{{Infobox drug | {{Infobox drug | ||
| drug_name = | | drug_name = | ||
| Line 10: | Line 8: | ||
| image2 = Haworth projection of ipragliflozin.svg | | image2 = Haworth projection of ipragliflozin.svg | ||
| width2 = 225 | | width2 = 225 | ||
| caption = [[Haworth projection]] (bottom) | | caption = [[Haworth projection/ja]] (bottom) | ||
<div lang="en" dir="ltr" class="mw-content-ltr"> | <div lang="en" dir="ltr" class="mw-content-ltr"> | ||